한글목차

세계의 양막 시장은 2024년에 37억 7,000만 달러로 평가되며, 2030년까지 CAGR 13.56%로 성장하며, 80억 9,000만 달러에 달할 것으로 예측됩니다. 태반의 가장 안쪽 층인 양막은 고유의 면역조절 작용, 항염증 작용, 항흉터 작용, 재생 특성으로 인해 다양한 의료 용도로 활용되는 생체조직입니다. 이 제품 시장은 당뇨병성 족부 궤양, 화상 등 만성 상처의 전 세계 유병률 증가와 안과 영역의 안구 표면 재건술에 대한 적용 확대가 주요 촉진요인으로 작용하고 있습니다.

주요 시장 성장 촉진요인

재생의료 및 줄기세포 연구의 지속적인 발전은 생물학적 치유 솔루션에 대한 이해와 적용을 확대함으로써 세계 양막 시장의 주요 원동력으로 작용하고 있습니다. 현재 진행 중인 연구를 통해 양막에 내재된 강력한 항염증, 항흉터 및 재생 능력이 밝혀져 보다 광범위한 질병에 대한 치료적 유용성이 입증되고 있습니다.

주요 시장 과제

문제는 양막 제품 및 관련 치료 프로토콜의 상대적으로 높은 비용에 있습니다. 이러한 높은 비용은 환자와 의료 서비스 프로바이더 모두에게 접근성에 큰 장벽을 만들어 세계 양막 시장의 성장을 크게 저해하고 있습니다.

주요 시장 동향

냉동 보존된 양막의 채택 증가는 장기적으로 생물학적 효능을 유지하는 보존 특성의 향상에 힘입어 중요한 시장 동향입니다. 동결보존 기술은 중요한 성장인자 및 세포외 매트릭스 성분을 보존할 수 있으며, 다른 보존 방법에 비해 우수한 치료 효과를 제공합니다.

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 양막 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 제품별(동결 보존, 탈수)
  • 용도별(외과적 창상, 안과, 기타)
  • 최종사용자별(병원, 외래 수술 센터(ASCs), 전문 클리닉, 조사·학술기관)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 양막 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 양막 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 양막 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 양막 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 양막 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병·인수
• 제품 출시
• 최근 동향

제13장 세계의 양막 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Alliqua BioMedical Inc.
• Amnio Technology LLC
• Applied Biologics
• Human Regenerative Technologies, LLC
• Integra LifeSciences Corporation
• MiMedx Group Inc.
• Skye Biologics Holdings, LLC
• BioTissue, Inc.
• Organogenesis, Inc.

제16장 전략적 제안

제17장 조사회사 소개·면책사항

영문목차

The Global Amniotic Membrane Market, valued at USD 3.77 Billion in 2024, is projected to experience a CAGR of 13.56% to reach USD 8.09 Billion by 2030. The amniotic membrane, the innermost layer of the placenta, is a biological tissue utilized in various medical applications due to its inherent immunomodulatory, anti-inflammatory, anti-scarring, and regenerative properties. The market for this product is primarily driven by the increasing global prevalence of chronic wounds, such as diabetic foot ulcers and burns, along with expanding applications in ophthalmology for ocular surface reconstruction.

Key Market Drivers

The continuous advancements in regenerative medicine and stem cell research serve as a primary catalyst for the Global Amniotic Membrane Market by expanding the understanding and applications of biological healing solutions. Ongoing research elucidates the potent anti-inflammatory, anti-scarring, and regenerative capabilities inherent in amniotic membranes, validating their therapeutic utility across a broader spectrum of conditions. These scientific breakthroughs translate into new product development and increased clinical acceptance.

Key Market Challenges

The challenge is the comparatively high cost of amniotic membrane products and the related treatment protocols. This elevated cost significantly impedes the growth of the Global Amniotic Membrane Market by creating substantial barriers to accessibility for both patients and healthcare providers. When treatment costs are high, healthcare systems, particularly those operating under stringent budget constraints, face difficulties in widely adopting these advanced therapies, thereby limiting the integration of amniotic membranes into standard care pathways.

Key Market Trends

The increasing adoption of cryopreserved amniotic membranes represents a significant market trend, driven by their enhanced preservation characteristics that maintain biological efficacy over extended periods. Cryopreservation techniques allow for the retention of vital growth factors and extracellular matrix components, offering superior therapeutic outcomes compared to other preservation methods. A multicenter study published in MDPI in July 2023, for instance, demonstrated the effectiveness of cryopreserved amniotic membrane allograft applications in wound healing, achieving approximately 69% healing capacity for nonhealing wounds, significantly higher than the 21% observed with standard of care treatments.

Key Market Players

• Alliqua BioMedical Inc.
• Amnio Technology LLC
• Applied Biologics
• Human Regenerative Technologies, LLC
• Integra LifeSciences Corporation
• MiMedx Group Inc.
• Skye Biologics Holdings, LLC
• BioTissue, Inc.
• Organogenesis, Inc.

Report Scope:

In this report, the Global Amniotic Membrane Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Amniotic Membrane Market, By Product:

• Cryopreserved
• Dehydrated

Amniotic Membrane Market, By Application:

• Surgical Wounds
• Ophthalmology
• Others

Amniotic Membrane Market, By End-User:

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Research And Academic Institutes

Amniotic Membrane Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Amniotic Membrane Market.

Available Customizations:

Global Amniotic Membrane Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Amniotic Membrane Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Cryopreserved, Dehydrated)
  • 5.2.2. By Application (Surgical Wounds, Ophthalmology, Others)
  • 5.2.3. By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research And Academic Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Amniotic Membrane Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Amniotic Membrane Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Amniotic Membrane Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Amniotic Membrane Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User

7. Europe Amniotic Membrane Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Amniotic Membrane Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. France Amniotic Membrane Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Amniotic Membrane Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Amniotic Membrane Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Amniotic Membrane Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. Asia Pacific Amniotic Membrane Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Amniotic Membrane Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Amniotic Membrane Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Amniotic Membrane Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Amniotic Membrane Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Amniotic Membrane Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-User

9. Middle East & Africa Amniotic Membrane Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Amniotic Membrane Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. UAE Amniotic Membrane Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. South Africa Amniotic Membrane Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. South America Amniotic Membrane Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Amniotic Membrane Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Colombia Amniotic Membrane Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. Argentina Amniotic Membrane Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Amniotic Membrane Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Alliqua BioMedical Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Amnio Technology LLC
• 15.3. Applied Biologics
• 15.4. Human Regenerative Technologies, LLC
• 15.5. Integra LifeSciences Corporation
• 15.6. MiMedx Group Inc.
• 15.7. Skye Biologics Holdings, LLC
• 15.8. BioTissue, Inc.
• 15.9. Organogenesis, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer